RENOWN REGIONAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7.6M
- Transactions
- 1,089
- Companies
- 40
- Average per transaction
- $6,977
Who reported the payments
| Merck | $1,512,400 |
| Pfizer | $1,084,252 |
| Genentech, Inc. | $720,808 |
| Eli Lilly | $633,804 |
| Novartis | $605,931 |
| Boehringer Ingelheim | $315,243 |
| Abbott | $238,359 |
| Amgen | $235,482 |
| Sanofi | $211,196 |
| Histosonics, Inc. | $209,034 |
| Stryker | $205,069 |
| E.r. Squibb & Sons, L.L.C. | $149,343 |
| Jazz Pharmaceuticals Inc. | $133,381 |
| Biosense Webster, Inc. | $127,600 |
| AbbVie | $107,891 |
| Konica Minolta Healthcare Americas, Inc | $98,550 |
| Gilead | $93,305 |
| AstraZeneca | $85,621 |
| Microvention, Inc. | $79,650 |
| Chugai Pharmaceutical Co., Ltd. | $67,141 |
| Bayer | $62,492 |
| Hoffmann-la Roche Limited | $62,342 |
| United Therapeutics Corporation | $59,365 |
| Spectrum Pharmaceuticals Inc. | $55,970 |
| Janssen Research & Development, LLC | $48,900 |
| Coherus Oncology, Inc. | $40,553 |
| Recor Medical Inc | $40,194 |
| Sanofi US Services Inc. | $37,833 |
| Daiichi Sankyo Inc. | $25,782 |
| Novocure Inc. | $25,210 |
| Insulet Corporation | $24,225 |
| Veru Inc. | $22,393 |
| Medtronic | $22,323 |
| Sanofi Pasteur Inc. | $21,183 |
| Halozyme Inc | $19,177 |
| Boehringer Ingelheim International GmbH | $18,554 |
| Masimo Corporation | $15,858 |
| Biohaven Pharmaceutical Holding Company Ltd. | $15,500 |
| GE HealthCare | $10,845 |
| Barco, Inc. | $5,649 |